Extrawell Pharmaceutical Holdings Limited's latest marketcap:

About Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited is an investment holding company specializing in the development, manufacturing, marketing, and distribution of pharmaceutical products. The company primarily operates in the People’s Republic of China and Hong Kong.

Business Segments

• Manufacturing: Produces pharmaceutical products such as transfer factor oral solution (immune regulator), Wisk (for skin injuries and wound healing), and ZhouBang (thromboxane synthetase inhibitor).
• Trading: Markets and distributes imported pharmaceuticals, including Skin-Cap (for skin conditions) and Millibar (for hypertension).
• Gene Development: Engages in genome-related technology development and commercialization.

Key Products

• Transfer factor oral solution – Treats viral infections and immune deficiencies.
• Wisk – Addresses skin injuries, burns, and ulcers.
• ZhouBang – Prevents platelet coagulation and aids blood vessel relaxation.
• Skin-Cap – Relieves itching, irritation, and skin conditions.
• Millibar – Manages high blood pressure.

Research & Development

The company is developing an oral insulin product, currently in clinical trials, for diabetes treatment.

Additional Activities

• Provides agency services.
• Engages in property investment.

Founded: 1998
Headquarters: Quarry Bay, Hong Kong